468. target validation Process to identify and assess whether a molecular target is likely to have therapeutic benefit.
469. targeted analysis Analysis of the composition of a complex sample by applying predefined selection criteria with the aim to quantify or verify the occurrence of previously identified sample components.
470. targeted quantitation Quantitation experiments to determine the protein and/or peptide levels of known targets in biological samples.
471. therapeutic drug monitoring Clinical monitoring of patient drug concentrations in plasma, serum or blood in order to enhance treatment efficacy or reduce toxicity. Typically used to treat patients taking marketed drugs with a narrow therapeutic range (those which can be easily under- or over-dosed), often abbreviated TDM.